Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 197 Breast Neoplasms 112 Neoplasms 83 Fatigue 29 Prostatic Neoplasms 27 Lung Neoplasms 20 Colorectal Neoplasms 20 Obesity 19 Polycystic Ovary Syndrome 14 Ovarian Neoplasms 11 Colonic Neoplasms 11 Carcinoma, Non-Small-Cell Lung 11 Rectal Neoplasms 10 Pancreatic Neoplasms 10 Lymphedema 10 Multiple Myeloma 9 Lymphoma 9 Hematologic Neoplasms 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Head and Neck Neoplasms 8 Weight Loss 7 Stomach Neoplasms 7 Cardiotoxicity 7 Peripheral Nervous System Diseases 6 Leukemia 6 Insulin Resistance 6 Esophageal Neoplasms 6 Brain Neoplasms 6 Sarcopenia 5 Endometrial Neoplasms 5

Interventions

High-Intensity Interval Training 1 Exercise 1 Cholecalciferol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Lupus Erythematosus, Systemic × Exercise × Clear all

NCT05478018 2025-09-09

LUPEX

Rigshospitalet, Denmark

Phase NA Completed

Lupus Erythematosus, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡